News

Jun 16,2021

KBP Biosciences Announces A Greater Than 10 mm Hg Systolic Blood Pressure Reduction in The BLOCK-CKD Phase 2b Study of KBP-5074 in Advanced Chronic Kidney Disease Patients with Uncontrolled Hypertension as Published in Hypertension

read more >>

Jun 07,2021

Cytek Biosciences Introduces a New High-Dimensional Sorter

read more >>

May 21,2021

Cardea Bio Partners with Scentian Bio to Power Insect Odorant Receptor-Enabled Flavor Profiling Product

read more >>

May 18,2021

MD Anderson and Refuge Biotechnologies Collaborate to Advance Next-Generation Cell Therapies for Treatment of Solid Tumors

read more >>

May 08,2021

Twist Bioscience Reports Second Quarter Fiscal 2021 Financial Results

read more >>

May 04,2021

Cardea Bio Develops Exosome and Extracellular Vesicles (EV) Detection Technology Called EV-Chip, Showcasing Cancer and Aging Dx Applications

read more >>

Apr 28,2021

Aravive Announces First Patient Dosed in Phase 3 Registrational Trial Evaluating AVB-500 in Patients with Platinum Resistant Ovarian Cancer

read more >>

Mar 30,2021

Immune-Onc Therapeutics Announces $73 Million in Series B1 and B2 Financing to Advance its Portfolio of Novel Immunotherapies in Blood Cancers and Solid Tumors

read more >>